Narrative Bio

Education
(1983-1987) M.D., Northwestern University Medical School, Chicago, IL
(1979-1983) B.S., Biology, Loyola University of Chicago, Chicago, IL
(1991-1992) Fellowship, The Edward Mallinckrodt Institute of Radiology, Washington University Medical School, St. Louis, MO

Post Graduate Training
(1988-1991) Resident, Radiation Oncology, Northwestern Memorial Hospital, Northwestern University Medical School, Chicago, IL
(1987-1988) Resident, Internal Medicine, Northwestern Memorial Hospital, Northwestern University Medical School, Chicago, IL

Faculty Appointments
(2017-Present) Professor - Clinical, Department of Oncology, Division of Radiation Oncology, Wayne State University School of Medicine, Detroit, MI
(2006-2017) Associate Professor, Department of Radiation Oncology, Wayne State University School of Medicine, Detroit, MI
(2014) Interim Chair, Department of Radiation Oncology, Wayne State University School of Medicine, Detroit, MI
(1995-2006) Assistant Professor, Department of Radiation Oncology, Wayne State University School of Medicine, Detroit, MI

Hospital or Other Professional Appointments
(2015-Present) Service Chief, Department of Oncology, Division of Radiation Oncology, Wayne State University School of Medicine, Detroit, MI
(2014-Present) Service Chief, Gershenson Radiation Oncology Center, Karmanos Cancer Institute, Harper University Hospital, Detroit, MI
(2014-Present) Clinical Competency Committee, Wayne State University School of Medicine, Wayne State University Physician Group, Karmanos Cancer Institute, Detroit, MI
(2014-Present) McLaren/Elekta Strategic Partnership Steering Committee, Karmanos Cancer Institute, Detroit, MI
(2014-Present) Clinical Quality Council, Karmanos Cancer Institute, Detroit, MI
(2014-Present) Head & Neck Research Working Group, Karmanos Cancer Institute, Detroit, MI
(2014-Present) Medical Executive Committee, Karmanos Cancer Institute, Detroit, MI
(2013-Present) Radiation Safety Committee, Gershenson Radiation Oncology Center, Karmanos Cancer Institute, Detroit, MI
(2011-Present) Leadership Committee, Gershenson Radiation Oncology Center, Karmanos Cancer Institute, Detroit, MI
(1995-Present) Attending Physician, Gershenson Radiation Oncology Center, Karmanos Cancer Center, Detroit, MI
(2008-2014) Clinical Chief, Gershenson Radiation Oncology Center, Karmanos Cancer Institute, Harper University Hospital, Detroit, MI
(2006-2008) Peer Review Committee, Karmanos Cancer Institute, Detroit, MI
(2003-2008) Data and Safety Monitoring Committee, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI
(2003-2007) Cancer Committee, Karmanos Cancer Institute, Detroit, MI
(2002-2009) Principal Investigator Committee Member, Head and Neck Cancer Committee Member, Radiation Therapy Oncology Group
(2001-2003) Protocol Review Committee, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI
(2000-2005) Head and Neck Cancer Committee Member, Southwest Oncology Group (SWOG)
(1999-2007) Consultant, Department of Radiation Oncology, John D. Dingell Veterans Administration Med Center, Detroit, MI
(1995-1997) Attending Physician and Clinical Chief, DMC Crittenton Radiation Oncology Center, Rochester, MI
(1993-1995) Attending Radiation Oncologist, Grant Medical Center, Columbus, OH
(1993) Attending Radiation Oncologist, St. Joseph Hospital, Pontiac, MI
(1992) Attending Radiation Oncologist, Oncology Care Center, Belleville, IL

Board Certification
(1992-Present) American Board of Radiology in Radiation Oncology

Areas of Interest

Central Nervous System Tumor
Head and Neck Cancer
Gamma Knife Stereotactic Radiosurgery
Comprehensive Ophthalmology
Stereotactic Radiosurgery
Stereotactic Body Radiotherapy
Traumatic Brain Injury

Publications

1. A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902. Rosenthal SA et al. Int J Radiat Oncol Biol Phys. (2015) High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3Randomized Trial NRG Oncology RTOG 9902. Rosenthal SA et al. Int J Radiat Oncol Biol Phys. (2015)
2. Wuthrick EJ, Zhang Q, Machtay M, Rosenthal DI, Nguyen-Tan PF, Fortin A, Silverman CL.Raben A, Kim HE, Horwitz EM, Read NE, Harris J, Wu Q, Le QT, Gillison ML. Institutional clinical trial accrual volume and survival of patients with head and neck cancer. J Clin Oncol. 2015 Jan 10;33(2):156-64. Doi: 10.1200/JCO2014.56.5218. Epub 2014 Dec 8. (Active participant in writing committee, reviewing manuscript, proposing and discussing revisions.)
3. Hurst NJ, Dominello M, Dyson G, Jaratli H, Sharma M, Ahmed YK, Melkane AE, Rose C, Jacobs J, Giorgadze T, Kim H. Intratumoral Lymphatic Vessel Density as a Predictor of Progression-Free and Overall Survival in Locally Advanced Laryngeal/Hypopharyngeal Cancer. Head Neck. 2015 Jan 10. Doi: 10.1002/hed.24011. (Active participant in writing committee, reviewing manuscript, proposing and discussing revisions.)
4. Nguyen-Tan PF, Zhang Q, Ang KK, Weber RS, Rosenthal DI, Soulieres D, Kim H, Silverman C, Raben A, Galloway TJ, Fortin A, Gore E, Westra WH, Chung CH, Jordan RC, Gillison ML, List M, Le QT. Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity. J Clin Oncol. 2014 Dec 1;32(34):3858-67. Doi: 10.1200/JCO.2014.55.3925. Epub 2014 Nov 3.
5. Amy L. Rutt, James P. Dworkin, Harry Kim, Richard Klapchar, Lisa Chiodo.Swallowing Function After Nonsurgical Treatment for Advanced Hypopharyngeal or Laryngeal Cancer. Journal of Medical Speech-Language Pathology. Volume 21, Number 4, pp. 357-368. 2014.
   

Position Title

Professor - Department of Oncology, Division of Radiation Oncology
Division Chief, Radiation Oncology
Service Chief, Karmanos Cancer Institute

← Return to listing